Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

7.08
Delayed Data
As of 4:04pm ET
 +0.16 / +2.31%
Today’s Change
4.81
Today|||52-Week Range
8.65
+4.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$710.2M

Company Description

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 420-3200
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeCFO, Treasurer, Principal Accounting Officer & VP
Gary IngenitoChief Medical & Regulatory Officer
Stanley IyaduraiVice President-Clinical Development